Evidence map›Paper›PMID 36184731›Full record

ArticleEuropean radiology experimental2022

The contribution of the

Miriam Dolciami, Rossella Canese, Claudia Testa, Angelina Pernazza, Giusi Santangelo, Innocenza Palaia, Carlo Della Rocca, Carlo Catalano, Lucia Manganaro

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European radiology experimental, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Polish journal of radiology · 2024
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Miriam DolciamiDepartment of Radiological, Oncological and Pathological Sciences, Policlinico Umberto I, Sapienza University of Rome, Rome, Italy.
Rossella CaneseCore Facilities, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161, Rome, Italy. rossella.canese@iss.it.ORCID 0000-0001-9093-6803
Claudia TestaDepartment of Physics and Astronomy, University of Bologna, Bologna, Italy.
Angelina PernazzaDepartment of Radiological, Oncological and Pathological Sciences, Policlinico Umberto I, Sapienza University of Rome, Rome, Italy.
Giusi SantangeloDepartment of Maternal and Child Health and Urological Sciences, Umberto I Hospital, "Sapienza" University of Rome, Rome, Italy.
Innocenza PalaiaDepartment of Maternal and Child Health and Urological Sciences, Umberto I Hospital, "Sapienza" University of Rome, Rome, Italy.
Carlo Della RoccaDepartment of Radiological, Oncological and Pathological Sciences, Policlinico Umberto I, Sapienza University of Rome, Rome, Italy.
Carlo CatalanoDepartment of Radiological, Oncological and Pathological Sciences, Policlinico Umberto I, Sapienza University of Rome, Rome, Italy.
Lucia ManganaroDepartment of Radiological, Oncological and Pathological Sciences, Policlinico Umberto I, Sapienza University of Rome, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe aim of this study was to investigate the role of the lipid peak derived from

methodsWe enrolled 17 patients with histologically proven cervical cancer who underwent 3-T MR imaging at baseline. In addition to conventional imaging sequences for pelvic assessment, the protocol included a single-voxel point-resolved spectroscopy (PRESS) sequence, with repetition time of 1,500 ms and echo times of 28 and 144 ms. Spectra were analysed using the LCModel fitting routine, thus extracting multiple metabolites, including lipids (Lip) and total choline (tCho). Patients with LACC were treated with NACT and reassessed by MRI at term. Based on tumour volume reduction, patients were classified as good responder (GR; tumour volume reduction > 50%) and poor responder or nonresponder (PR-or-NR; tumour volume reduction ≤ 50%).

resultsOf 17 patients, 11 were LACC. Of these 11, only 6 had both completed NACT and had good-quality

conclusionsAssessment of lipid peak at

Indexed as

Uterine Cervical NeoplasmsCholineFemaleHumansLipidsMagnetic Resonance ImagingProton Magnetic Resonance SpectroscopyCholineLipidsCholineLipidsMagnetic resonance imagingProton magnetic resonance spectroscopyUterine cervical neoplasms

Identifiers

PMID36184731
PMCPMC9527268

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.